| Targeting androgen receptor for prostate cancer therapy: From small molecules to PROTACs | | 2022 |
| Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort | | |
| Metastatic Prostate Adenocarcinoma Presenting as Acute Quadriplegia: A Case Report and Racial Disparity Analysis | | 2022 |
| Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment | | |
| Disease Burden of Prostate Cancer from 2014 to 2019: Estimation from the Global Burden of Disease Study 2019 and Medical Expenditure Panel Survey. | | |
| Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions | | 2022 |
| Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CT | | 2022 |
| Should Contemporary Western Guidelines Based on Studies Conducted in the 2000s Be Adopted for the Prostate-Specific Antigen Screening Policy for Asian Men in the 2020s? | | |
| Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends | Clinical Drug Investigation | |
| Detection of Circulating Glial Cells Enables Non-Invasive Diagnosis of Glial Malignancies | | |
| Is docetaxel-free interval a predictive factor for castration-resistant prostate cancer? | Actas Urológicas Españolas (English Edition) | 2022 |
| US Population Reference Values for Health-Related Quality of Life Questionnaires Based on Demographics of Patients with Prostate Cancer | Advances in Therapy | |
| ¿Es el intervalo libre de docetaxel un factor predictivo para el cáncer de próstata resistente a la castración? | Actas Urológicas Españolas | 2022 |
| Primary Tumor Staging and Detection of Common Sites of Distant Metastatic Disease | | 2022 |
| A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer | European Urology | 2022 |
| Pathological Roles of Reactive Oxygen Species in Male Reproduction | Advances in Experimental Medicine and Biology | 2022 |
| 99mTc-PSMA SPECT in Prostate Cancer | Clinical and Translational Imaging | |
| Accurate Prostate Cancer Detection based on Circulating Tumor Cell Profiling | | |
| Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality. | JAMA Network Open | 2022 |
| Lutetium Lu 177 Vipivotide Tetraxetan: First Approval. | Molecular Diagnosis and Therapy | 2022 |
| Office-Based, Single-Sided, Low-Field MRI-Guided Prostate Biopsy | Cureus | 2022 |
| Lower fracture rates in patients treated with Radium-223, abiraterone or enzalutamide, when given concurrently with bone health agents: A real world analysis | Clinical Genitourinary Cancer | 2022 |
| A narrative review of biparametric MRI (bpMRI) implementation on screening, detection, and the overall accuracy for prostate cancer. | Therapeutic Advances in Urology | 2022 |
| Racial/Ethnic Differences in Health-Related Quality of Life Among Gay and Bisexual Prostate Cancer Survivors. | Frontiers in Oncology | 2022 |
| Evaluation of maintenance of the common androgen deprivation therapy with the new antiandrogen therapy in patients with castration-resistant prostate cancer: a systematic review. | International Urology and Nephrology | 2022 |
| Focal prostate cancer therapy in the era of multiparametric MRI: a review of options and outcomes. | Prostate Cancer and Prostatic Diseases | 2022 |
| Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients with Non-Metastatic Castration-Resistant Prostate Cancer. | Urology | 2022 |
| PSA Testing in Men Receiving Testosterone Therapy with History of Prostate Cancer: A Matched Analysis of a Large Multi-Institutional Research Network. | Urology | 2022 |
| Development of a novel castration-resistant orthotopic prostate cancer model in New Zealand White rabbit. | Prostate | 2022 |
| Assessing the impact of decision aid use on post prostatectomy patient reported outcomes. | Urology | 2022 |
| Development of a Sexual Quality of Life Questionnaire for Men-Who-Have-Sex-With-Men With Prostate Cancer. | Sexual Medicine | 2022 |
| Re: NCCN Prostate Cancer Guidelines Version 1.2022 - September 10, 2021. | European Urology | 2021 |
| Promoting informed prostate cancer screening decision-making for African American men in a community-based setting. | Cancer Causes and Control | 2022 |
| Biomarkers in Urinary Tract and Male Genital System Carcinomas | | 2022 |
| Population-based survival for cancer patients in Saudi Arabia for the years 2005-2009. | Scientific Reports | 2022 |
| Examination of prostate-specific antigen (PSA) screening in military and civilian men: analysis of the 2018 behavioral risk factor surveillance system. | Cancer Causes and Control | 2022 |
| Metastatic Prostate Adenocarcinoma: A Rare Presentation. | Cureus | 2022 |
| Racial Differences in Prostate Cancer Characteristics and Cancer-Specific Mortality: An Overview. | World Journal of Men?s Health | 2022 |
| El índice nutricional pronóstico como factor pronóstico independiente para la respuesta al tratamiento, la supervivencia y la elección del fármaco en el cáncer de próstata metastásico resistente a la castración tratado con acetato de abiraterona o enzalutamida | Actas Urológicas Españolas | 2021 |
| Targeted Radionuclide Therapy and Immunotherapy of Metastatic Prostate Cancer | | 2022 |
| Improved survival with post-diagnostic metformin and statin use in a racially diverse cohort of US Veterans with advanced prostate cancer | Prostate Cancer and Prostatic Diseases | 2021 |
| Estimating the Financial Impact of Gene Therapy* | | |
| Nutraceuticals and Wellness | | 2020 |
| The Handbook of Wellness Medicine | | 2020 |
| Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent | Frontiers in Oncology | 2021 |
| A Jaw-Dropping Diagnosis | Journal of Hospital Medicine | 2020 |
| Virtue Chapter | | 2020 |
| ADC mapping with 12 b values: an improved technique for image quality in diffusion prostate MRI | | |
| Comparative study between monoexponential and biexponential diffusion weighted imaging sequences in multiparametric prostate magnetic resonance imaging | Einstein (Sao Paulo, Brazil) | 2019 |
| Transition from normal to cancerous cell by precancerous niche (PCN) induced chronic cell-matrix stress | 4open | 2019 |
| Evaluation and Treatment for High-Risk Prostate Cancer | | 2018 |
| Screening for Prostate Cancer:: Making sense of the US Preventative Services Task Force 2017 Draft Recommendation Statement | Delaware Journal of Public Health | 2017 |
| Experience with abiraterone acetate in the treatment of metastatic prostate cancer | Onkologiya Zhurnal Imeni P A Gertsena | 2016 |
| Experience with abiraterone acetate in the treatment of metastatic prostate cancer | Onkologiya Zhurnal Imeni P A Gertsena | 2015 |
| Prostate and Bladder Carcinomas: Histology, Immunohistochemistry, Genetic Biomarkers | | 2015 |
| Assessing the Enormity of the Problem | | 2015 |
| Prostate zones and cancer: lost in transition? | Nature Reviews Urology | 2021 |
| The Effect of Maximum Tumor Diameter by MRI on Disease Control in Intermediate and High-risk Prostate Cancer Patients Treated With Brachytherapy Boost | Clinical Genitourinary Cancer | 2021 |
| Impact of diverticular disease on prostate cancer risk among hypertensive men | Prostate Cancer and Prostatic Diseases | 2021 |
| Lemur Tyrosine Kinase 2, a novel target in prostate cancer therapy | Oncotarget | 2015 |
| Computer aided detection in prostate cancer diagnostics: A promising alternative to biopsy? A retrospective study from 104 lesions with histological ground truth | PLoS ONE | 2017 |
| Geographic analysis of urologist density and prostate cancer mortality in the United States | PLoS ONE | 2015 |
| A genome-wide RNAi screen identifies FOXO4 as a metastasis-suppressor through counteracting PI3K/AKT signal pathway in prostate cancer | PLoS ONE | 2014 |
| Statin use and risk of prostate cancer: a meta-analysis of observational studies | PLoS ONE | 2012 |
| Deep Genomic Signature for early metastasis prediction in prostate cancer | | |
| Prostate Cancer | | 2017 |
| Gay Men and Prostate Cancer: Opportunities to Improve HRQOL and Access to Care | | 2015 |
| Evidence-Based Practice in Clinical Behavioral Oncology | | 2014 |
| Understanding temporal trends in medical costs associated with progression to metastatic prostate cancer | Cancer | 2017 |
| Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials | World Journal of Urology | 2021 |
| [Artificial intelligence in the diagnosis of prostate cancer] | Arkhiv Patologii | 2021 |
| Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study | European Urology | 2021 |
| A most vulnerable population: Black men | Nursing Forum | 2021 |
| Patient Preferences and Treatment Decisions for Prostate Cancer: Results From A Statewide Urological Quality Improvement Collaborative | Urology | 2021 |
| A Hybrid Human-Machine Learning Approach for Screening Prostate Biopsies Can Improve Clinical Efficiency Without Compromising Diagnostic Accuracy | Archives of Pathology and Laboratory Medicine | 2021 |
| Impact of Age and Race on Health-Related Quality of Life Outcomes in Patients Undergoing Radical Prostatectomy for Localized Prostate Cancer | Urology | 2021 |
| Prostate Cancer in Older Adults: Risk of Clinically Meaningful Disease, the Role of Screening and Special Considerations | Current Oncology Reports | 2021 |
| Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors | Advances in Therapy | 2021 |
| Prostate cancer survival in sub-Saharan Africa by age, stage at diagnosis, and human development index: a population-based registry study | Cancer Causes and Control | 2021 |
| Intraprostatic calcification and biochemical recurrence in men treated with cesium-131 prostate brachytherapy | Brachytherapy | 2021 |
| Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers | Clinical Journal of Oncology Nursing | 2021 |
| Comparative analysis of long-term results of external beam and combined radiotherapy in high-risk prostate cancer patients | Malignant Tumours | 2021 |
| Survival in Patients With Metastatic Prostate Cancer Undergoing Radiotherapy: The Importance of Prostate-Specific Antigen-Based Stratification | Frontiers in Oncology | 2021 |
| Yet Another Automated Gleason Grading System (YAAGGS) by weakly supervised deep learning | Npj Digital Medicine | 2021 |
| Onboarding Materials as Cross-functional Boundary Objects for Developing AI Assistants | | 2021 |
| Management of Lower Urinary Tract Symptoms after Prostate Radiation | Current Urology Reports | 2021 |
| An up-to-date evaluation of abiraterone for the treatment of prostate cancer | Expert Opinion on Pharmacotherapy | 2021 |
| The role of routine follow-up visits of prostate cancer survivors in addressing supportive care and information needs: a qualitative observational study | Supportive Care in Cancer | 2021 |
| Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis | JAMA Oncology | 2021 |
| Epidemiology and genomics of prostate cancer in Asian men | Nature Reviews Urology | 2021 |
| An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy | Modern Pathology | 2021 |
| Factors predicting biochemical response and survival benefits following radioligand therapy with [Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review | European Journal of Nuclear Medicine and Molecular Imaging | 2021 |
| Urodynamic evaluation of patients with localized prostate cancer before and 4 months after robotic radical prostatectomy | Scientific Reports | 2021 |
| Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review | Journal of General Internal Medicine | 2021 |
| A Cost-Effectiveness Analysis of Systemic Therapy for Metastatic Hormone-Sensitive Prostate Cancer | Frontiers in Oncology | 2021 |
| Prostate Carcinogenesis: Insights in Relation to Epigenetics and Inflammation | Endocrine, Metabolic and Immune Disorders - Drug Targets | 2021 |
| Identification of patients with metastatic castration-sensitive or metastatic castration-resistant prostate cancer using administrative health claims and laboratory data | Current Medical Research and Opinion | 2021 |
| Prospective Observational Study of a Racially Diverse Group of Men on Active Surveillance for Prostate Cancer | Urology | 2021 |
| Treatment and resistance mechanisms in castration-resistant prostate cancer: new implications for clinical decision making? | Expert Review of Anticancer Therapy | 2021 |
| Prostate Cancer Diagnosis in the Clinic Using an 8-Protein Biomarker Panel | Analytical Chemistry | 2021 |
